Monkey Anti-SARS-CoV-2 Spike Protein S1
(monkey polyclonal antisera)
Immunogen: CHO-expressed full length S1 with human IgG Fc fusion.
Specificity: Recognizes SARS-CoV-2 Spike Protein S1, with in vitro Virus neutralizing activity.
Formulation: 0.1ml monkey polyclonal anti-sera
Physical State: Frozen liquid
FOR IN VITRO RESEARCH USE ONLYNOT FOR USE IN HUMANS
Research Applications
Neutralizing assay: virus neutralizing titer >1:1000.
ELISA: to be used at 1:500 dilution as positive control
Storage: Store the product at -20℃. Product is stable for about 6weeks at 2-8℃ as an undiluted liquid. Prepare working dilutionfresh each day. Avoid repeated freezing and thawing.
References:
Zhao RQ, et al. “Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection”, submitted. preprint:
https://www.medrxiv.org/content/10.1101/2020.03.17.20037713v1.full.pdf.
Ren WL, et al. “A COVID-19 vaccine based on the spike S1 protein with a novel adjuvant induces high level of neutralizing responses in nonhuman primates” submitted.
